Answers are grounded in this paper and cite their sources.
Cervical cancer is one of the most common cancers among women in developing countries. Human papilloma virus (HPV) with sexually transmitted infection is the major causative agent and risk factor for developing cervical cancer. Women aged between "21-65 years" are the major risk group for cervical cancer. Increase in incidence and mortality rate due to cervical cancer, led to interventions for preventing and screening of this disease. Pap smear and HPV test are the two major screening techniques. According to National Cancer Institute, HPV vaccines can prevent cancerous and pre-cancerous cases infected by high risk HPV. Recent advancement by targeting specific genes provides new scope in the treatment of cervical cancer.
No takes yet. Share an insight, caveat, or question.
Anusha Sudulaguntla (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: